Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
8018820
Reference Type
Journal Article
Subtype
Review
Title
Inner ear drug delivery for auditory applications
Author(s)
Swan, EE; Mescher, MJ; Sewell, WF; Tao, SL; Borenstein, JT
Year
2008
Is Peer Reviewed?
Yes
Journal
Advanced Drug Delivery Reviews
ISSN:
0169-409X
Volume
60
Issue
15
Page Numbers
1583-1599
Language
English
PMID
18848590
DOI
10.1016/j.addr.2008.08.001
Web of Science Id
WOS:000261649800003
Abstract
Many inner ear disorders cannot be adequately treated by systemic drug delivery. A blood-cochlear barrier exists, similar physiologically to the blood-brain barrier, which limits the concentration and size of molecules able to leave the circulation and gain access to the cells of the inner ear. However, research in novel therapeutics and delivery systems has led to significant progress in the development of local methods of drug delivery to the inner ear. Intratympanic approaches, which deliver therapeutics to the middle ear, rely on permeation through tissue for access to the structures of the inner ear, whereas intracochlear methods are able to directly insert drugs into the inner ear. Innovative drug delivery systems to treat various inner ear ailments such as ototoxicity, sudden sensorineural hearing loss, autoimmune inner ear disease, and for preserving neurons and regenerating sensory cells are being explored.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity